Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Medtronic Endovascular

Clinical trials sponsored by Medtronic Endovascular, explained in plain language.

Now part of Medtronic plc MDT NYSE

A subsidiary of Medtronic, focused on endovascular devices.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Not yet finished but already full! 1 Completed 1 Terminated 1

New device for dialysis access shows promise in 142 patients

Disease control Completed

This study looked at how well the Ellipsys Vascular Access System works for creating arteriovenous (AV) fistulas in people with end-stage kidney disease who need dialysis. A total of 142 patients were followed for 12 months to see how long the access stayed open and how safe the …

Phase: NA • Sponsor: Medtronic Endovascular • Aim: Disease control

Last updated Jun 27, 2026 13:01 UTC